How to: Managing a Newly Inherited Panel of Patients being treated with Opioids for Pain - December 20, 2023
This site is for learners who attended the live December 20, 2023, program to claim credit.
Claiming Credit
Thank you for participating in this program. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to complete the evaluation and claim your credit on the following page.
Target Audience
Primary care physicians, internists, family practice physicians, nurse practitioners, nurses, and physician assistants
Learning Objectives
- Describe issues of importance in evaluating an opioid legacy patient.
- Develop reasoned expectations for outcomes of legacy patients.
- Describe and access a MCSTAP consultation.
- Provide safe, appropriate care to a patient receiving chronic opioid pain therapy.
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1 hour of opioid education.
ADA statement: To request reasonable accommodations for a disability please contact MCSTAP@beaconhealthoptions.com, in writing, at least two weeks prior to the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 MA Opioid Education Statement
- 1.00 Participation